Home » News » Awards & Advancement » Frost & Sullivan names Seven Bridges product leader in genomics informatics

Frost & Sullivan names Seven Bridges product leader in genomics informatics

Friday, June 16, 2017

Seven Bridges, a provider of biomedical data analysis, received the Frost & Sullivan Product Leadership Award for the Genomics Informatics Industry.

The award recognizes Seven Bridges’ success in enabling pharmaceutical research and development, in addition to national genomics projects, and establishes the company as the market leader in this fast-growing industry.

“Frost & Sullivan firmly believes Seven Bridges offers a suite of biomedical data analysis tools, along with the scientific team, that make it the go-to provider of genomics informatics solutions for large pharmaceutical companies and national scientific projects,” said Christi Bird Ulan, senior research analyst, at Frost & Sullivan. “For its commitment to reducing bottlenecks and challenges in the genomics industry through its easy-to-use yet high-capability platform, Seven Bridges is the ideal recipient of the Frost & Sullivan Product Leadership Award in the genomics informatics industry.”

Seven Bridges builds software to analyze multi-omics and clinical data, accelerating research and improving health outcomes. It combines deep expertise in scientific computation and bioinformatics to support the world’s largest biomedical research projects across industry and government, including the U.S. National Cancer Institute’s Cancer Genomics Cloud pilot, the Million Veteran Program, and Genomics England’s 100,000 Genomes Project. Seven Bridges has been recognized by various publications for its leading role in biomedical data analysis, including three Bio-IT World Best of Show awards—most recently in 2017—and the MIT Technology Review’s 50 Smartest Companies award.

“Seven Bridges is the pioneer developing technologies to help researchers integrate petabyte-scale biomedical data into all stages of their work, which leads to new discoveries and improved health,” said Brandi Davis-Dusenbery, CEO of Seven Bridges. “We are honored to receive this award from Frost & Sullivan; it validates the work of our team and clients.”

The Frost & Sullivan Product Leadership Award recognizes companies that provide consistently high standards of product or service quality or innovation. To determine the award recipient, analysts independently evaluate companies across two key factors divided into 10 benchmarking criteria. Seven Bridges received top ratings for both product attributes and business impact, with a clear lead over its competitors in both categories.

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!